Endothelins (ET) have opposite vascular effects mediated through different receptors: ET A receptors mediating vasoconstriction and ET B receptors mediating vasoconstriction as well as vasodilation. The role of ET in acute hypoxic pulmonary vasoconstriction (HPV) was studied after dual ET receptor blockade with bosentan and nitric oxide (NO) synthase inhibition with nitro-Larginine (L-NA). We started from the hypothesis that ET antagonism may inhibit HPV but, if not, would do so after NO synthase inhibition. HPV was evaluated in anesthetized lambs, with an intact pulmonary circulation, by the increase in the mean pulmonary artery pressure (Ppa) minus occluded Ppa (Ppao) gradient in response to hypoxia (inspiratory oxygen fraction of 0.1) at different levels of pulmonary flow (multipoint pressure/flow relationships). ET receptor antagonism decreased pulmonary and systemic vascular tone both in hyperoxia and hypoxia. ET antagonism had no effect on HPV. NO synthase inhibition increased pulmonary vascular tone more in hypoxia than in hyperoxia so that HPV was enhanced. After L-NA, bosentan still decreased pulmonary vascular tone in hypoxia but did not affect the magnitude of HPV. The present results suggest that ET and NO are involved in the regulation of basal pulmonary vascular tone. Furthermore, the vasodilator effect of bosentan persisted in the presence of NO synthase inhibition, suggesting a non NO-dependent vasodilator mechanism. The results from these experiments are in agreement with the idea that ET do not play a major role in HPV in the perinatal lamb, even when it is enhanced by NO synthase inhibition. (Pediatr Res 59: 131-136, 2006) E T are powerful vasoactive mediators synthesized and released by the vascular endothelium (1). Plasma levels of circulating ET-1, the predominant isoform of ET, vary with age: in the fetus and newborn infants they are higher than in neonates and infants up to 3 months of age; they then become nearly constant and similar to adult levels (2-4). ET-1 plasma levels are also elevated in newborns and children suffering from diseases associated with pulmonary hypertension (PHT) and are correlated with the severity of the disease (5-7).ET have opposite vascular effects mediated through different receptors. ET A receptors, located on vascular smooth muscle cells, mediate ET-1 vasoconstriction. ET B receptors are found on vascular smooth muscle cells, where they mediate vasoconstriction, and also on endothelial cells, where their stimulation produces vasodilation, presumably through the endothelial synthesis of NO and prostacyclin (8,9). Activation of the ET B receptor mediates pulmonary clearance of circulating ET-1 and reuptake of ET-1 by endothelial cells (8). In addition, although it is generally proposed that endothelial NO synthesis is related to ET-B receptor stimulation (8 -11), another study shows that activation of ET-A receptors also can enhance NO production in the vasculature (12). In experimental studies on the regulation of the pulmonary vascular tone in peri...